R. Lor Randall, MD, FACS, discusses the potential symptoms and presentation of mesenchymal chondrosarcoma, as well as highlighted recent case studies that he consulted on for patients with mesenchymal chondrosarcoma.
R. Lor Randall, MD, FACS
Advertisement
R. Lor Randall, MD, FACS, is the David Linn Endowed Chair for Orthopedic Surgery and chair of the Department of Orthopedic Surgery as well as a professor at the University of California Davis.
Articles by R. Lor Randall, MD, FACS
R. Lor Randall, MD, FACS, discusses, the importance of correctly diagnosing mesenchymal chondrosarcoma.
R. Lor Randall, MD, FACS, discusses methods of preventing early failures with compressive osseointegrative endoprosthetic devices of the femur in bone sarcomas.
R. Lor Randall, MD, FACS, discusses the evolution of limb salvage technologies in bone sarcomas.
R. Lor Randall, MD, FACS, discusses initial considerations when treating patients with desmoid tumors.
R. Lor Randall, MD, FACS, discusses the evolution of orthopedic surgery in sarcoma.
R. Lor Randall, MD, FACS, discusses the SAFETY trial (NCT03944798) in soft tissue sarcoma.
R. Lor Randall, MD, FACS, discusses ongoing research in sequencing the tumors of patients with primary bone or tissue sarcomas.
R. Lor Randall, MD, FACS, discusses using pexidartinib to treat tenosynovial giant cell tumor.
Advertisement
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma
2
NP-G1-044 Receives FDA Orphan Drug Designation for Pancreatic Cancer
3
Ixazomib-Based Regimens Expand Options in Relapsed/Refractory Multiple Myeloma
4
PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer
5